A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors

Authors

A. Craig Lockhart, Washington University School of Medicine in St. LouisFollow
et alFollow

Journal

Oncotarget

Publication Date

2015

Volume

6

Issue

19

Inclusive Pages

17905- 17918

Document Type

Open Access Publication

Rights and Permissions

A. Craig Lockhart, et al. A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors. Oncotarget. 2015 Jun 19; 17905-17918.

Recommended Citation

Lockhart, A. Craig and et al, "A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors." Oncotarget. 6, 19. 17905- 17918. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4009